60 related articles for article (PubMed ID: 16506595)
1. Human embryonal tissues of all three germ layers can express the CD30 antigen. An immunohistochemical study of 30 fetuses coming after therapeutic abortions from week 8th to week 16th of gestation.
Tamiolakis D; Maroulis G; Simopoulos C; Verettas D; Papadopoulos N; Venizelos J; Lambropoulou M; Koutsougeras G; Karpouzis A; Kouskoukis C
Cesk Patol; 2006 Jan; 42(1):9-15. PubMed ID: 16506595
[TBL] [Abstract][Full Text] [Related]
2. Ber-H2 (CD30) immunohistochemical staining of human fetal tissues.
Tamiolakis D; Papadopoulos N; Lambropoulou M; Venizelos J; Verettas D; Tsikouras P; Koutsougeras G; Papadopoulos H; Karpouzis A; Kouskoukis C
Int J Biol Sci; 2005; 1(4):135-40. PubMed ID: 16244703
[TBL] [Abstract][Full Text] [Related]
3. Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Bolioti S; Tsiapali M; Verettas D; Tsikouras P; Chatzimichail A; Papadopoulos N
Theor Biol Med Model; 2005 Jan; 2():1. PubMed ID: 15644135
[TBL] [Abstract][Full Text] [Related]
4. CD30 (Ki-1) molecule expression in human embryonal epithelial cells of the basal layer of the developing epidermis and epidermal buds and its potential significance for embryogenesis.
Tamiolakis D; Papadoupoulos N; Venizelos I; Lambropoulou M; Tsikouras P; Koutsougeras G; Bolioti S; Tsiapali M; Karpouzis A; Kouskoukis C
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):85-90, 92. PubMed ID: 16200333
[TBL] [Abstract][Full Text] [Related]
5. Expression of the CD30 antigen in non-lymphoid tissues and cells.
Dürkop H; Foss HD; Eitelbach F; Anagnostopoulos I; Latza U; Pileri S; Stein H
J Pathol; 2000 Apr; 190(5):613-8. PubMed ID: 10727988
[TBL] [Abstract][Full Text] [Related]
6. Human decidual cells can express the Hodgkin's cell-associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.
Papadopoulos N; Galazios G; Anastasiadis P; Kotini A; Stellos K; Petrakis G; Zografou G; Polihronidis A; Tamiolakis D
Clin Exp Obstet Gynecol; 2001; 28(4):225-8. PubMed ID: 11838744
[TBL] [Abstract][Full Text] [Related]
7. NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development.
Tamiolakis D; Papadopoulos N; Venizelos J; Lambropoulou M; Tsikouras P; Koutsougeras G; Bolioti S; Tsiapali M; Menegaki M; Kouskoukis C
Clin Exp Med; 2005 Dec; 5(4):184-9. PubMed ID: 16362798
[TBL] [Abstract][Full Text] [Related]
8. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma.
Polski JM; Janney CG
Mod Pathol; 1999 Sep; 12(9):903-6. PubMed ID: 10496599
[TBL] [Abstract][Full Text] [Related]
9. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma.
Pallesen G; Hamilton-Dutoit SJ
Am J Pathol; 1988 Dec; 133(3):446-50. PubMed ID: 2849300
[TBL] [Abstract][Full Text] [Related]
10. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.
Latza U; Foss HD; Dürkop H; Eitelbach F; Dieckmann KP; Loy V; Unger M; Pizzolo G; Stein H
Am J Pathol; 1995 Feb; 146(2):463-71. PubMed ID: 7856755
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
Lau SK; Thomas P; Weiss LM
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):273-7. PubMed ID: 20090517
[TBL] [Abstract][Full Text] [Related]
12. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
14. Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia/lymphoma (ATLL) in US/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy.
Yao J; Gottesman SR; Ayalew G; Braverman AS; Axiotis CA
Am J Surg Pathol; 2013 Sep; 37(9):1407-12. PubMed ID: 23797717
[TBL] [Abstract][Full Text] [Related]
15. CD30 (Ber-H2) expression by thymocytes and thymic epithelial cells during the late first and second trimester of gestation: an immunohistochemical and in situ hybridization (ISH) study.
Lambropoulou M; Tamiolakis D; Venizelos I; Nikolaidou S; Bolioti S; Limberis V; Galazios G; Tsikouras P; Koutsougeras G; Karamanidis D; Papadopoulos N
Med Sci Monit; 2007 Dec; 13(12):BR280-5. PubMed ID: 18049429
[TBL] [Abstract][Full Text] [Related]
16. High expression of the CD30 molecule in human decidual cells.
Ito K; Watanabe T; Horie R; Shiota M; Kawamura S; Mori S
Am J Pathol; 1994 Aug; 145(2):276-80. PubMed ID: 8053487
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
[TBL] [Abstract][Full Text] [Related]
18. CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications.
de Bruin PC; Gruss HJ; van der Valk P; Willemze R; Meijer CJ
Leukemia; 1995 Oct; 9(10):1620-7. PubMed ID: 7564499
[TBL] [Abstract][Full Text] [Related]
19. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
